腹部普通外科、结直肠、上消化道及肝胆胰手术血栓与出血手术特异性风险的系统评价与Meta分析
该研究纳入285项观察性研究(8,048,635例患者),覆盖40种普通腹部、36种结直肠、15种上消化道及24种肝胆胰手术,估计术后4周症状性静脉血栓栓塞症(VTE)和大出血的累积发生率。VTE风险从腹腔镜胆囊切除术的中位<0.1%到开腹小肠切除的3.7%不等;部分手术(如开腹结肠切除和开腹胰十二指肠切除)血栓预防净获益,而另一些(如腹腔镜胆囊切除和择期腹股沟疝修补)则相反。
要点
- VTE风险因手术而异,从腹腔镜胆囊切除中位<0.1%到开腹小肠切除中位3.7%。
- 结直肠手术VTE风险从微创乙状结肠切除0.3%到急诊开腹全结直肠切除10.0%。
- 上消化道/肝胆胰手术VTE风险从腹腔镜袖状胃切除0.2%到开腹远端胰腺癌切除6.8%。
核心结论
- VTE血栓预防通过降低VTE在某些手术中提供净获益,但出血小幅增加(如开腹结肠切除和开腹胰十二指肠切除),而在另一些手术中则相反(如腹腔镜胆囊切除和择期腹股沟疝修补)。
- 在许多手术中,血栓栓塞和出血风险相似,决策取决于个体风险预测以及对VTE和出血的价值观和偏好。
研究设计与样本
- 系统评价与Meta分析,纳入报告腹部手术后症状性VTE或大出血手术特异性风险的观察性研究。
- 共纳入285项研究(8,048,635例患者),覆盖40种普通腹部、36种结直肠、15种上消化道和24种肝胆胰手术。
- 对报告的估计值按血栓预防和随访时间进行调整,估计术后4周累积发生率,按VTE风险组分层,并评定证据确定性。
主要发现
- VTE证据确定性一般为中等或低,需再干预的出血证据确定性为低或极低。
- 普通腹部手术VTE风险中位从腹腔镜胆囊切除术的<0.1%到开腹小肠切除的3.7%。
- 结直肠手术VTE风险从微创乙状结肠切除的0.3%到急诊开腹全结直肠切除的10.0%。
- 上消化道/肝胆胰手术VTE风险从腹腔镜袖状胃切除的0.2%到开腹远端胰腺癌切除的6.8%。
局限性
- VTE证据确定性一般为中等或低,需再干预的出血证据确定性为低或极低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide procedure-specific estimates of symptomatic venous thromboembolism (VTE) and major bleeding after abdominal surgery. BACKGROUND: The use of pharmacological thromboprophylaxis represents a trade-off that depends on VTE and bleeding risks that vary between procedures; their magnitude remains uncertain. METHODS: We identified observational studies reporting procedure-specific risks of symptomatic VTE or major bleeding after abdominal surgery, adjusted the reported estimates for thromboprophylaxis and length of follow-up, and estimated cumulative incidence at 4 weeks postsurgery, stratified by VTE risk groups, and rated evidence certainty. RESULTS: After eligibility screening, 285 studies (8,048,635 patients) reporting on 40 general abdominal, 36 colorectal, 15 upper gastrointestinal, and 24 hepatopancreatobiliary surgery procedures proved eligible. Evidence certainty proved generally moderate or low for VTE and low or very low for bleeding requiring reintervention. The risk of VTE varied substantially among procedures: in general abdominal surgery from a median of <0.1% in laparoscopic cholecystectomy to a median of 3.7% in open small bowel resection, in colorectal from 0.3% in minimally invasive sigmoid colectomy to 10.0% in emergency open total proctocolectomy, and in upper gastrointestinal/hepatopancreatobiliary from 0.2% in laparoscopic sleeve gastrectomy to 6.8% in open distal pancreatectomy for cancer. CONCLUSIONS: VTE thromboprophylaxis provides net benefit through VTE reduction with a small increase in bleeding in some procedures (eg, open colectomy and open pancreaticoduodenectomy), whereas the opposite is true in others (eg, laparoscopic cholecystectomy and elective groin hernia repairs). In many procedures, thromboembolism and bleeding risks are similar, and decisions depend on individual risk prediction and values and preferences regarding VTE and bleeding.
引用
- Lavikainen LI, Guyatt GH, Sallinen VJ, et al. Systematic Reviews and Meta-analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper Gastrointestinal, and Hepatopancreatobiliary Surgery. Ann Surg. 2023. PMID: 37551583. doi:10.1097/SLA.0000000000006059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。